Joint Research Committee Responsibilities Clause Samples
The Joint Research Committee Responsibilities clause defines the roles and duties assigned to a committee established to oversee collaborative research efforts between parties. Typically, this clause outlines how the committee is formed, the frequency of meetings, decision-making procedures, and the scope of its authority, such as approving research plans, monitoring progress, and resolving disputes. By clearly delineating these responsibilities, the clause ensures effective coordination, accountability, and smooth management of joint research activities, thereby minimizing misunderstandings and facilitating successful collaboration.
Joint Research Committee Responsibilities. The JRC shall have the following responsibilities:
(a) monitoring the progress of the Research Collaboration and of the conduct by the Parties of all research activities thereunder;
(b) providing a forum for consensual discussion with respect to the Research Collaboration and of the conduct by the Parties of all research activities thereunder with the goal of having one or more Research Compounds achieve the applicable Criteria;
(c) reviewing data, reports or other information submitted by the Parties with respect to work conducted in the Research Collaboration; and
(d) discussing such other matters as appropriate with respect to the Research Collaboration during the Research Collaboration Term.
Joint Research Committee Responsibilities. The JRC generally shall have the responsibility of managing, directing and coordinating the Research Program, including, without limitation, the following responsibilities:
a. managing and monitoring the progress and results of the Research Program and the Parties’ diligence in carrying out their responsibilities thereunder;
b. determining future Research Program activities to be conducted under the Research Plan;
c. allocating responsibility for the various Research Program activities between the Parties;
e. reviewing and approving modifications of the Research Plan from time to time *****; and
Joint Research Committee Responsibilities. The Joint Research Committee shall oversee implementation and execution of the Collaborative Research Plan. The Joint Research Committee shall be responsible for planning, managing, directing and overseeing specific activities under its areas of responsibility, including but not limited to the following, any of which may be delegated to an Operating Committee, as the Joint Research Committee deems appropriate consistent with the goals of the Collaboration:
(a) reviewing the Collaborative Research Plan from a scientific and operational perspective;
(b) making changes to the portions of the Collaborative Research Plan relating to the Target Validation Program and the Antisense Drug Discovery Program as it deems necessary to accomplish the purpose of the Collaboration, so long as such changes do not cause the Collaboration to exceed the budget established for the Target Validation Program and the Antisense Drug Discovery Program in the Collaborative Research Plan, as such budget may be amended by the Executive Committee;
(c) proposing other changes to the Collaborative Research Plan to the Executive Committee as it deems necessary to accomplish the purpose of the Collaboration;
(d) prioritizing and monitoring progress of antisense lead identification for the Reagent Provision Program, Target Validation Program and Drug Discovery Program; provided, however, that if there is a disagreement concerning the prioritization of a Reagent Target or a Validation Target, such disagreement shall be appealed to the Executive Committee, and, in the event the Executive Committee is unable to resolve such disagreement, such prioritization shall be decided by Lilly;
(e) reviewing the progress and results of the Collaboration to ensure, to the extent reasonably practical, that the Parties are meeting their commitments for both human and financial support and are each fulfilling all of their respective contractual obligations;
(f) reviewing the qualifications of the Collaboration FTEs to ensure that the Parties are meeting the intent of the Collaborative Research Plan;
(g) referring disputes or appealing decisions to the Executive Committee as necessary;
(h) approving changes to the allocation of Collaboration Funds set forth in the Collaborative Research Plan (i) within the Reagent Provision Program, (ii) between the Target Validation Program and the Antisense Drug Discovery Program and (iii) among the Collaboration Therapeutic Areas, so long as such changes do not cause the C...